hydrazine has been researched along with Neonatal Alloimmune Thrombocytopenia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Neunert, CE; Rose, MJ | 1 |
| Ferrer-Marin, F; Gutti, RK; Liu, ZJ; Sallmon, H; Sola-Visner, MC | 1 |
1 review(s) available for hydrazine and Neonatal Alloimmune Thrombocytopenia
| Article | Year |
|---|---|
Romiplostim for the management of pediatric immune thrombocytopenia: drug development and current practice.
Topics: Adrenal Cortex Hormones; Benzoates; Child, Preschool; Clinical Trials as Topic; Cloning, Organism; Drug Development; Hemorrhage; History, 20th Century; Humans; Hydrazines; Immunoglobulins; Infant; Injections, Subcutaneous; Platelet Count; Practice Guidelines as Topic; Purpura, Thrombocytopenic, Idiopathic; Pyrazoles; Receptors, Fc; Receptors, Thrombopoietin; Recombinant Fusion Proteins; Safety; Splenectomy; Thrombocytopenia, Neonatal Alloimmune; Thrombopoietin; United States; United States Food and Drug Administration | 2019 |
1 other study(ies) available for hydrazine and Neonatal Alloimmune Thrombocytopenia
| Article | Year |
|---|---|
Increasing platelets without transfusion: is it time to introduce novel thrombopoietic agents in neonatal care?
Topics: Adult; Age Factors; Apoptosis; Benzoates; Brain; Dose-Response Relationship, Drug; Drug Approval; Humans; Hydrazines; Infant, Newborn; Neurons; Patient Selection; Platelet Transfusion; Purpura, Thrombocytopenic, Idiopathic; Pyrazoles; Receptors, Fc; Receptors, Thrombopoietin; Recombinant Fusion Proteins; Thrombocytopenia, Neonatal Alloimmune; Thrombopoiesis; Thrombopoietin; United States; United States Food and Drug Administration | 2010 |